Ovarian germ cell tumors (OGCTs) are a rare subset of ovarian cancers, originating from the primitive germ cells of the embryonic gonad. They primarily affect adolescents and young women, often presenting with abdominal pain and masses. Research advancements have significantly improved the prognosis for OGCTs, with multimodal treatments combining surgery and chemotherapy proving highly effective. Chemotherapeutic regimens, particularly those including platinum-based compounds, have shown high cure rates even in advanced stages. Ongoing studies focus on minimizing treatment-related toxicity and exploring the molecular genetics of OGCTs to develop targeted therapies. Innovations in fertility preservation are also enhancing quality of life for survivors, addressing a critical concern for this young patient demographic.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States